Crinone

Short answer There’s no single “best” BHRT delivery form for everyone. Choice depends on your symptoms, medical risks, need for precise dosing, convenience, and whether you need local (vaginal) vs systemic therapy. General patterns: patches = predictable, non‑invasive, lower blood clot risk than oral; creams = convenient but absorption unpredictable (compounded creams vary); pellets = long‑acting and convenient for some patients but invasive and harder to adjust. What each option is good for — pros and cons Pellets (subcutaneous pellets of estradiol/testosterone) Pros: steady hormone release for months, good for people who don’t want daily dosing, may improve adherence. Cons: minor procedure to insert/remove; dose can’t be adjusted easily until next insertion; pellets are usually compounded (less regulatory oversight); evidence is mostly observational; possible local infection or extrusion. Who offers them: BioTE (a national training/product company used by many clinics), SottoPelle (international pellet network), specialty hormone clinics and some OB/GYNs/urologists. Many local compounding pharmacies supply pellets used by those clinics. Creams/gels (topical or vaginal) Pros: easy to apply, good for localized vaginal symptoms if you use approved vaginal formulations, compounding allows customized dosing. Cons: systemic absorption is highly variable for skin creams; many over‑the‑counter “natural” creams don’t deliver reliable systemic levels; compounded creams are not FDA‑standardized and potency can vary. Useful products/services: For local vaginal symptoms (best evidence): Estrace cream (estradiol cream, prescription), Vagifem (vaginal estradiol tablet), Estring (vaginal ring). For systemic topical therapy often via compounding: many compounding pharmacies (Wedgewood, Empower, Belmar, etc.) make bioidentical creams or gels — but quality and consistency vary. Patches (transdermal) Pros: steady, predictable systemic absorption; easier to dose-adjust than pellets; transdermal estradiol associated with lower venous thromboembolism (VTE) risk vs oral estrogen in most studies; available as FDA‑approved products. Cons: skin irritation for some, visible patch, must change regularly (e.g., twice weekly). Common brands: Vivelle‑Dot/Alora/Minivelle (estradiol patches), Climara (estradiol), Menostar (low‑dose estradiol for bone health), Combipatch (estradiol + norethindrone for women who need progestin). Progesterone/protection of the uterus If you have a uterus and use systemic estrogen, you generally also need progestogen to prevent endometrial hyperplasia/cancer. Evidence‑backed options: oral micronized progesterone (Prometrium), vaginal progesterone (Crinone), or FDA‑approved combined transdermal systems (e.g., some combos). Compounded progesterone creams are commonly used but often don’t reach reliably protective systemic levels. Safety and evidence notes “Bioidentical” means the hormone molecule is chemically identical to human hormones, but formulation, dosing, and route matter more than the label. Many FDA‑approved estradiol products are bioidentical (e.g., patches, creams, rings). Compounded products and custom pellets are less regulated and have more variability. Randomized controlled trial data comparing pellets vs patches vs creams is limited. Transdermal estrogen (patch/gel) has the strongest safety data regarding clot risk compared with oral estrogen. Always review personal risk factors (history of clotting, stroke, breast cancer, liver disease, smoking, age) with a clinician before starting BHRT. Who offers them (examples) Pellet therapy networks/companies: BioTE (BioTE Medical clinics/trainings), SottoPelle (pellet specialists). Many private hormone clinics and some OB/GYN/urology practices also insert pellets. Patches/spray/approved vaginal options: prescription products available through your primary care/OB‑GYN/endocrinologist and filled at retail pharmacies. Brands: Vivelle‑Dot, Climara, Alora, Minivelle, Menostar, Combipatch, Evamist (spray), Estrace (vaginal cream), Vagifem, Estring. Compounded creams/gels/pellets: major compounding pharmacies include Wedgewood Pharmacy, Empower Pharmacy, Belmar Pharmacy (and others). Use a reputable, accredited compounding pharmacy (e.g., USP‑compliant, PCAB accreditation where possible). Clinics that offer BHRT (including telehealth + in‑person options): BodyLogicMD (franchise of hormone clinics), some concierge/endocrine clinics, many board‑certified OB‑GYNs and endocrinologists who specialize in menopause/HRT. If you want pellets specifically, search for BioTE or SottoPelle certified providers in your area. How to decide (practical steps) Define your goals: relieve hot flashes? Improve libido? Vaginal dryness? Bone health? Testosterone for low libido? This affects route choice. Review risk factors with a clinician (clotting, cancer history, heart disease, liver disease). Prefer FDA‑approved options first (patches, vaginal products) when appropriate. Consider compounded or pellet routes if standard options fail or you have a clear reason and you’re comfortable with the tradeoffs. If using compounded products or pellets, pick clinicians and pharmacies with good credentials and follow‑up care (lab monitoring and symptom review). Plan monitoring (symptoms, periodic labs, breast/cervical/endometrial screening as indicated). If you want a tailored recommendation Tell me: your main symptoms and goals, whether you have a uterus, relevant medical history (clotting, cancer, heart disease), and whether you prefer fewer procedures (daily vs monthly vs yearly). I can suggest the most appropriate routes and give names of local providers or telehealth services.

Mentioned in position 16 of 18

Short answer: Bioidentical hormone replacement therapy (BHRT) can be safe and effective for treating menopausal symptoms when prescribed and monitored appropriately — but there’s an important distinction doctors make between FDA‑approved “bioidentical” hormones and unregulated compounded BHRT. Most professional medical societies recommend FDA‑approved products and caution about compounded preparations. Key points doctors and medical organizations say “Bioidentical” simply means the hormone molecule is chemically identical to the human hormone (e.g., 17β‑estradiol, micronized progesterone). That alone doesn’t guarantee safety. FDA‑approved bioidentical hormones (standard prescription products) have documented dosing, quality control, and clinical-trial data on benefits and risks. Clinicians generally prefer these because they are regulated and tested. Compounded BHRT (custom creams, troches, gels made by compounding pharmacies) lacks the same regulation and consistent dosing. Major bodies — North American Menopause Society (NAMS), American College of Obstetricians and Gynecologists (ACOG), the Endocrine Society and the FDA — warn that claims about “customized” or “safer/natural” compounded hormones are not well supported by evidence. Risks of hormone therapy depend on type/dose/route and patient factors (age, time since menopause, medical history). Known risks of systemic estrogen (especially combined estrogen–progestin) include increased risk of blood clots, stroke, and, with long‑term use, possible increased breast cancer risk. Transdermal estrogen may have lower clot risk than oral estrogen; micronized progesterone may have a more favorable profile than some synthetic progestins. Saliva hormone testing (often marketed by BHRT clinics) is unreliable for guiding dosing; most doctors do not use it for management. Practical, doctor‑oriented guidance If you and your clinician decide on hormone therapy, prefer FDA‑approved, regulated products when possible (predictable dosing, safety data). Use the lowest effective dose for symptoms and reassess regularly. If you have a uterus and are taking systemic estrogen, you need an appropriate progestogen to protect the endometrium. Discuss personal risk factors (breast cancer history, clotting disorders, cardiovascular disease, liver disease, smoking) before starting. Get regular follow‑up: symptom review, screening (mammography), and labs guided by your clinician. Specific FDA‑approved products doctors commonly use (examples) Estradiol (oral/transdermal/vaginal): Estrace (oral), Climara / Estraderm / Vivelle‑Dot / Alora (patches), Vagifem (vaginal tablet), Estring (vaginal ring) Micronized progesterone: Prometrium (oral); Crinone, Endometrin (vaginal progesterone preparations) Combination product: Bijuva (oral estradiol + progesterone capsule) Testosterone (for men: AndroGel, Testim, Androderm — for women, testosterone therapy is off‑label and used cautiously with limited evidence) If you’re considering compounded BHRT Be cautious. Ask the prescriber why a compounded product is needed instead of an FDA‑approved product. If you still choose compounding, use a pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) or one with strong quality control, and request certificates of analysis and USP compliance. Expect close follow‑up and objective clinical endpoints (symptoms, safety monitoring) rather than saliva tests. Trusted resources and organizations North American Menopause Society (NAMS) — position statements and patient info American College of Obstetricians and Gynecologists (ACOG) The Endocrine Society FDA consumer information on BHRT and compounded hormones Major medical centers: Mayo Clinic, Cleveland Clinic (reliable patient guides) Bottom line BHRT can be a safe, effective option if you use evidence‑based, FDA‑approved hormones under a clinician’s supervision and with appropriate monitoring. Be skeptical of claims that compounded BHRT is inherently safer or more “natural,” and avoid saliva testing as a dosing guide. Talk with a gynecologist, endocrinologist, or a menopause specialist about which option fits your symptoms and risks. If you’d like, tell me your age, symptoms, medical history (e.g., history of clotting, breast cancer, heart disease), and whether you’re already on any hormones — I can help summarize the pros and cons for your situation and suggest questions to ask a clinician.

Mentioned in position 9 of 19